About: Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1999 (uk) im Januar 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1999 (ast) artikull shkencor i botuar më 01 janar 1999 (sq) scientific article published on 01 January 1999 (en)
publication date	wds:Q77304798-0166ADE3-B68D-4AE8-B054-8B076286C24A
publication date	1999-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q77304798-6F3C5EC2-F494-4E5D-9AA1-2C3C7B7D1D71
exact match	https://scigraph.springernature.com/pub.10.1038/sj.bmt.1701540
author name string	wds:Q77304798-3223B149-C47D-40DD-A9F0-8D258FBFD3C9 wds:Q77304798-3F7F2F4D-C632-452E-8A78-0884955D13E2 wds:Q77304798-88FE9D06-B515-4983-A9B4-93DB9A1045E9 wds:Q77304798-E2DAC11F-EC2E-4E81-B97D-8DED8E373157 wds:Q77304798-E41D4173-A5F7-4379-98B6-95D61BEBCAAB
author name string	Seymour JF Bardy P Grigg A Szer J Byron K
rdfs:label	Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (en) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (nl) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (sq)
skos:prefLabel	Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (en) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (nl) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (sq)
name	Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (en) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (nl) Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (sq)
title	wds:Q77304798-66FD62F5-E624-4CBD-A169-9E6E2101B492
title	Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphoma (en)
page(s)	wds:Q77304798-413F1F96-DD1D-4416-BED8-91116682D335
page(s)	107-110
instance of	wds:Q77304798-73D548D9-CA95-4327-832F-70096868A03B
instance of	scholarly article
main subject	wds:Q77304798-5F32F813-676D-4608-B264-F3E3965F3E86
main subject	chemotherapy
PubMed ID	wds:Q77304798-384B4249-C623-4A44-91FC-84A3A81F6625
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10197793
PubMed ID	10197793
published in	wds:Q77304798-F3BAFB51-AAD1-4161-A71E-11893B436730
published in	Bone Marrow Transplantation
issue	wds:Q77304798-43678B55-B6E7-4C22-9774-229D4534BF4D
volume	wds:Q77304798-85EEBCCF-39F8-4A9C-8FA0-40A9BE33D2B9
issue	2
volume	23
DOI	wds:Q77304798-32F76AD1-2EC2-4329-BFB1-B3466D53203C
DOI	http://dx.doi.org/10.1038/SJ.BMT.1701540
DOI	10.1038/SJ.BMT.1701540
Dimensions Publication ID	wds:Q77304798-13D407C3-15C2-42BB-84C3-05E5D06A8A5E
Dimensions Publication ID	1051808451
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77304798
is cites work of	Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning? Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma Stem cell transplantation for mantle cell lymphoma: if, when and how? Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II). The graft-versus-lymphoma effect: clinical review and future opportunities Clinical pharmacokinetics of nucleoside analogues: focus on haematological malignancies Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies Follicular lymphomas--a review of treatment modalities. Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review Granisetron plus dexamethasone versus granisetron alone in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era Nonmyeloablative stem cell transplantation with fludarabine and cyclophosphamide for patients with hematologic malignancies.
is cites work of	wds:Q34720883-E9183FF3-A580-42FF-A2D7-70C21488C8DF wds:Q43198291-5A870B44-25A9-474C-A2B7-C5626C8AA409 wds:Q43561532-36C88C44-5FD2-4679-8223-D2C627E7E1E9 wds:Q34116907-B6C03B23-A1CB-4121-BCD2-447926E1497B wds:Q44303055-794C2CD6-7E8A-4696-8924-5EAD73DF62D2 wds:Q36188687-C30E2752-3424-4F4C-BC27-6D0442BA3D17 wds:Q33341143-B3BA0D87-7572-494E-A828-F6308C0FD3E6 wds:Q73552901-6C9637B9-65D5-4F67-868D-1E3DE8A31DF6 wds:Q36128232-95F29ACF-0C4F-456F-A38D-657CD7979FBA wds:Q33342453-5656076A-3D11-456E-837C-36F8B66450ED wds:Q33991278-E5F5238D-D701-41FB-B7D7-C82FCFC167C1 wds:Q33947861-60887C99-97D5-41DD-8121-853EF6839E75 wds:Q37071972-E9F2C7FB-11C6-4717-9D68-60256C19B8CE wds:Q38119863-BC397A4D-9C57-4BB2-83E2-54D0179C2CD8 wds:Q44670745-0B608192-C132-4945-9604-47C99513BA32 wds:Q35022487-EB649F4B-C864-4D52-A084-BF5A450F72C2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software